Darren Santiago

发表

Cancer Immunity 3:19 (2003)-ARTICLE

V. Reuter, P. Sharma, Yao-Tseng Chen, 2003 .

Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer.

Yao-Tseng Chen, J. Ji, L. Old, 2004, Cancer immunity.

Targets for Immunotherapy in Epithelial Ovarian Cancer NY-ESO-1 and LAGE-1 Cancer-Testis Antigens Are Potential

L. Old, D. Driscoll, M. Intengan, 2003 .

Vaccine-Induced CD4+ T Cell Responses to MAGE-3 Protein in Lung Cancer Patients1

Yao-Tseng Chen, D. Atanackovic, N. Altorki, 2004, The Journal of Immunology.

Th1/Th2 CD4+ T cell responses against NY-ESO-1 in HLA-DPB1*0401/0402 patients with epithelial ovarian cancer.

K. Odunsi, L. Old, S. Gnjatic, 2004, Cancer immunity.

Th 1 / Th 2 CD 4 + T cell responses against NY-ESO-1 in HLA-DPB 1 * 0401 / 0402 patients with epithelial ovarian cancer

K. Odunsi, L. Old, S. Gnjatic, 2004 .

MAGE-3 Protein in Lung Cancer Patients T Cell Responses to + Vaccine-Induced CD4

Yao-Tseng Chen, D. Atanackovic, N. Altorki, 2004 .

SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.

K. Odunsi, L. Old, D. Driscoll, 2004, Cancer immunity.

Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.

V. Reuter, P. Sharma, Yao-Tseng Chen, 2003, Cancer immunity.

NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

Yao-Tseng Chen, K. Odunsi, L. Old, 2003, Cancer research.

Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients.

Gerd Ritter, Dirk Jäger, D. Jäger, 2003, Cancer immunity.